ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Preliminary Results of Coxsackievirus With Pembrolizumab In Advanced Melanoma

Ann W. Silk, MD
Published Online:2:25 PM, Mon April 10, 2017

Ann W. Silk, MD, assistant professor, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, discusses preliminary results of the CAPRA trial, a phase 1B study of intratumoral coxsackievirus A21 (CVA21; CAVATAK) and systemic pembrolizumab in patients with advanced melanoma.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.